Contact Us

Ceeable to Participate with the American Medical Association at TEDMED 2016

Award winning technology prevents blindness with a mobile digital healthcare solution
    BOSTON, MA, December 02, 2016 /24-7PressRelease/ -- Ceeable, Inc. today announced that management will participate in the 2016 TEDMED conference with the American Medical Association (AMA) to be held November 30-December 2, 2016, at The La Quinta Resort in Palm Springs, California.

The TEDMED conference bridges the gap between science and the public by finding and sharing stories that inform, inspire, engage and provoke action across a broad, passionate community both inside and outside of health and medicine. The annual event brings some of the worlds experts together to focus on what's new and important in health and medicine. In collaboration with the AMA Ceeable will have an opportunity broaden its audience and reach to potential customers and partners.

Ceeable, Inc. is a leader in digital mobile health for ophthalmology. The Ceeable Visual Field Analyzer (CVFA) is cloud-based digital platform used to detect and diagnose retinal disease. There are more that 300 million people worldwide that suffer from retinal disease. The Ceeable technology can reach more people worldwide than any currently available retinal diagnostic technology. Better patient management of eye disease will reduce healthcare systems costs and help to prevent blindness.

# # #

Read more Press Releases from Chris Adams:

Comment on this story...

Share This Story

Email this Story

Contact Information

Chris Adams

Somerville, MA
Voice: 617-957-9858
E-Mail: Email Us Here
Website: Visit Our Website

Like This Story?

I like it! 0


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.